FDA Grants AP Status for Prednisolone ANDA219509 by TP ANDA Holdings
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Prednisolone submitted by TP ANDA Holdings.
Asset / Drug
Drug and asset intelligence for Prednisolone with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.